UiPath has completed the acquisition of WorkFusion, a company focused on AI agents purpose-built for financial crime compliance. The deal has already closed and was completed during UiPath’s first ...

UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged the S&P 500's daily gain of 0.26%. Elsewhere, the Dow gained 0.6%, while the ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

UiPath CFO and COO Ashim Gupta outlines why the company’s recent progress rests less on agentic AI re-positioning and more on execution discipline – from renewals and deployment rigor to how ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

IonQ could become one of the biggest winners in quantum computing. UiPath has a huge opportunity in the agentic AI field. GitLab looks misunderstood. If you're looking for some potential ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Enzymes help with specific functions that are vital to the operation and overall health of the human body. They help speed up chemical reactions and are essential for respiration, digestion, muscle ...

Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced ...